tiprankstipranks
Mirati Therapeutics (MRTX)
NASDAQ:MRTX

Mirati Therapeutics (MRTX) Technical Analysis

386 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
4Neutral
7Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Mirati Therapeutics’s (MRTX) Moving Averages Convergence Divergence (MACD) indicator is 0.37, suggesting Mirati Therapeutics is a Buy.
Mirati Therapeutics’s (MRTX) 20-Day exponential moving average is 58.69, while Mirati Therapeutics’s (MRTX) share price is $58.7, making it a Buy.
Mirati Therapeutics’s (MRTX) 50-Day exponential moving average is 57.02, while Mirati Therapeutics’s (MRTX) share price is $58.7, making it a Buy.

Mirati Therapeutics (MRTX) Pivot Points

Apr 29, 2024, 12:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
58.07
58.35
58.58
58.86
59.09
59.37
59.60
Fibonacci
58.35
58.55
58.67
58.86
59.06
59.18
59.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Mirati Therapeutics (MRTX) Moving Averages

Apr 29, 2024, 12:30 AM
Period
Simple
Exponential
MA5
58.83Sell
58.82Sell
MA10
58.94Sell
58.87Sell
MA20
58.94Sell
58.69Buy
MA50
57.69Buy
57.02Buy
MA100
52.15Buy
53.25Buy
MA200
45.47Buy
48.06Buy
Mirati Therapeutics’s (MRTX) 10-Day exponential moving average is 58.87, while Mirati Therapeutics’s (MRTX) share price is $58.7, making it a Sell.
Mirati Therapeutics’s (MRTX) 100-Day exponential moving average is 53.25, while Mirati Therapeutics’s (MRTX) share price is $58.7, making it a Buy.
Mirati Therapeutics’s (MRTX) stock price is $58.7 and Mirati Therapeutics’s (MRTX) 50-day simple moving average is 57.69, creating a Buy signal.
Mirati Therapeutics’s (MRTX) stock price is $58.7 and Mirati Therapeutics’s (MRTX) 100-day simple moving average is 52.15, creating a Buy signal.
Mirati Therapeutics’s (MRTX) stock price is $58.7 and Mirati Therapeutics’s (MRTX) 200-day simple moving average is 45.47, creating a Buy signal.

Mirati Therapeutics (MRTX) Technical Indicators

Apr 29, 2024, 12:30 AM
Name
Value
Implied Action
RSI (14)
56.15
Neutral
STOCH (9,6)
15.80
Buy
STOCHRSI (14)
20.83
Neutral
MACD (12,26)
0.37
Buy
ADX (14)
48.52
Neutral
Williams %R
-82.61
Buy
CCI (14)
-172.90
Buy
ATR (14)
0.43
-
Ultimate Oscillator
39.61
Neutral
ROC
-0.09
Sell
Mirati Therapeutics’s (MRTX) Relative Strength Index (RSI) is 56.15, creating a Neutral signal.
Mirati Therapeutics’s (MRTX) Trend Strength Indicator (ADX) is 48.52, creating a Neutral signal.
Mirati Therapeutics’s (MRTX) Commodity Channel Index (CCI) is -172.90, creating a Buy signal.
Mirati Therapeutics’s (MRTX) Price Rate of Change (ROC) is -0.09, creating a Sell signal.

FAQ

Is MRTX a Buy, Hold, or Sell?
Based on MRTX’s technical indicators, MRTX is a Buy.
    What is MRTX’s RSI (14)?
    MRTX’s RSI (14) is 56.15, which suggests MRTX is a Neutral.
      What is MRTX’s MACD?
      MRTX’s MACD is 0.37, which suggests MRTX is a Buy.
        What is MRTX’s 5-day moving average?
        MRTX’s 5-day moving average is 58.83, which suggests MRTX is a Sell.
          What is MRTX’s 20-day moving average?
          MRTX 20-day moving average is 58.94, which suggests MRTX is a Sell.
            What is MRTX’s 50-day moving average?
            MRTX’s 50-day moving average is 57.69, which suggests MRTX is a Buy.
              What is MRTX’s 200-day moving average?
              MRTX’s 200-day moving average is 45.47, which suggests MRTX is a Buy.
                What is MRTX’s Williams % R (14)?
                MRTX’s Williams % R (14) is -82.61, which suggests MRTX is a Buy.
                  What is MRTX’s CCI (14)?
                  MRTX’s CCI (14) is -172.90, which suggests MRTX is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis